Bandingkan Harga & Kinerja Hexindo Adiperkasa Tbk. (HEXA) vs Indofarma Tbk. (INAF)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Hexindo Adiperkasa Tbk. dan Indofarma Tbk.: Hexindo Adiperkasa Tbk. diperdagangkan di Rp4.460 (kapitalisasi pasar 3,75 T, volume 24 jam 384,1 rb), sedangkan Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M). Perbedaan utamanya: Hexindo Adiperkasa Tbk. jauh lebih besar — sekitar 9,6× kapitalisasi pasar Indofarma Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| HEXA | INAF | |
|---|---|---|
Kapitalisasi Pasar | 3,75 T | 390,51 M |
Volume | 384,1 rb | — |
Lot | 3,84 rb | — |
Perputaran | 1,71 M | — |
Harga Rata-rata | 4.456,78 | — |
Nilai Transaksi | 1,71 M | — |
Harga Ekuilibrium Indikatif | 4.460 | — |
Volume Ekuilibrium Indikatif | 107 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Hexindo Adiperkasa Tbk.
PT Hexindo Adiperkasa Tbk (the Company) was established on November 28, 1988 based on notarial deed No.37 of Mohamad Ali. The deed of establishment was approved by the Ministry of Justice in its decision letter No. C2-4389.HT.01.01.TH.89 dated May 12, 1989 and was published in Supplement No. 1251 of the State Gazette No.54 dated July7, 1989. Presently, the Company acts as a distributor of certain heavy equipment and related spare parts with the trademark of Hitachi, John Deere and Ammann. The Company’s registration statement for the public offering of its 10 million shares of stocks (with Rp 1000 per value per share) at on offer price of Rp 2,800 per share become affective in accordance with the letter No.S-1958/PM/1994 dated December 5, 1994 issued by the Chairman of the Capital Market Supervisory Agency (BAPEPEAM). The excess of the proceeds over the par value of the shares of stock was recorded as “Capital paid in excess of par value”. The Company’s registration statement for the first limited public offering of 42 million shares to stockholders with pre-emptive rights (with Rp 1,000 per value per share) at an offer price of Rp 1,000 per share became effective in accordance with the letter No.S-1264/PM/1998 dated June 19, 1998 issued by the Chairman of BAPEPAM.
Selengkapnya di halaman HEXA →Tentang Indofarma Tbk.
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →
